EC Number   |
Application |
Reference |
|---|
    5.4.99.7 | drug development |
results identify a particularly promising new family of OSC inhibitors, for the development of novel antiparasitic agents |
662756 |
| 5.4.99.7 | drug development |
the enzyme represents a novel target for treatment of hypercholesterolemia and atherosclerosis |
663443 |
| 5.4.99.7 | drug development |
the enzyme represents a target for the discovery of novel anticholesteraemic drugs |
662943 |
| 5.4.99.7 | medicine |
S23515 can exert hypolipidemic effects in addition to its hypotensive activities |
661036 |
| 5.4.99.7 | medicine |
since the Shumiya cataract rat model represents a new example of hereditary cholesterol deficiency-associated cataracts, it should be useful in the development of therapeutic and/or preventive measures for cataracts |
662517 |
| 5.4.99.7 | medicine |
target for the development of new hypocjolesterolemic drugs |
649634 |
| 5.4.99.7 | nutrition |
since lanosterol synthase is located in the middle stage of the biosynthetic pathway of cholesterol in mammals, it may be important to know the acyl composition of digalactosyl diacylglycerol in vegetables for evaluating the efficacy of them against hypercholesterolemia |
661342 |
| 5.4.99.7 | synthesis |
engineering ERG7 for producing biological active agents is promising |
727106 |
